CD4 and myeloid sarcoma: Similarly to MS, proliferation rates and pro-inflammatory cytokine production of myelin-reactive CD4+ T cells were higher, and anti-inflammatory cytokine IL-10 production was lower than healthy controls, consistent with a TH1/TH17 immune phenotype (25).